Inozyme Pharma Inc (INZY)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current INZY market cap is 64.06M. The company's latest EPS is USD -1.5882 and P/E is -0.63.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.81M | -24.35M | -27.66M | -24.85M | -27.17M |
| Net Income | -21.54M | -23.35M | -27.03M | -24.57M | -27.07M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -57.04M | -56.65M | -68.68M | -75.65M | -104.03M |
| Net Income | -56.42M | -56.62M | -67.06M | -71.17M | -102.02M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 200.85M | 176.94M | 155.71M | 143.36M | 123.18M |
| Total Liabilities | 60.37M | 58.11M | 61.29M | 60.57M | 65.36M |
| Total Equity | 140.48M | 118.84M | 94.42M | 82.79M | 57.83M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 169.36M | 123.54M | 139.2M | 200.85M | 123.18M |
| Total Liabilities | 11.26M | 14.27M | 20.8M | 60.37M | 65.36M |
| Total Equity | 158.1M | 109.27M | 118.39M | 140.48M | 57.83M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -70.68M | -24.53M | -48.19M | -72.72M | -91.91M |
| Investing | -53.65M | 10.39M | 28.21M | 51.56M | 67M |
| Financing | 125.97M | 159k | 617k | 11.14M | 11.4M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -35.97M | -48.15M | -57.76M | -70.68M | -91.91M |
| Investing | -117.18M | 42.8M | -5.4M | -53.65M | 67M |
| Financing | 149.81M | 609k | 72.79M | 125.97M | 11.4M |
| Market Cap | 64.06M |
| Price to Earnings Ratio | -0.63 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.05 |
| Price to Book Ratio | 1.11 |
| Dividend Yield | - |
| Shares Outstanding | 64.24M |
| Average Volume (1 week) | 422.13k |
| Average Volume (1 Month) | 459.01k |
| 52 Week Change | -78.65% |
| 52 Week High | 6.24 |
| 52 Week Low | 0.721 |
| Spread (Intraday) | 0.17 (15.21%) |
| Company Name | Inozyme Pharma Inc |
| Address |
corporation trust center 1209 orange st wilmington, delaware 19801 |
| Website | https://www.inozyme.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
